• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Blogs » The Carlat Psychiatry Blog » Stimulant Medications for ADHD: Choosing the Right Approach for Adults Free Quick Reference Guide

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

General Psychiatry

Stimulant Medications for ADHD: Choosing the Right Approach for Adults Free Quick Reference Guide

June 6, 2026
Greg Malzberg, MD
PDF

Gregory Malzberg, MD. Attending Psychiatrist & Assistant Clinical Professor, Mount Sinai West, New York, NY. Creator, PsychoFarm.

Dr. Malzberg has no financial relationships with companies related to this material. 

ADHD_Course_Graphic.png
Stimulant Medications for ADHD: Choosing the Right Approach for Adults | Carlat Psychiatry
ADHD
Quick Reference Guide Adult ADHD: Comprehensive Diagnosis and Treatment Module 3

Treatment Overview

Key Statistics

  • First-line treatment for ADHD
  • ~70% respond to initial stimulant
  • ~90% respond when trying both classes
  • 40% respond equally to both classes
  • 20% respond to only one class

Key Medication Classes

Methylphenidate

  • Blocks dopamine/norepinephrine reuptake
  • Often safer starting option
  • Better for patients with anxiety/mood disorders
  • Examples: Concerta, Ritalin, Focalin

Amphetamines

  • Blocks reuptake AND increases neurotransmitter release
  • More potent but higher side effect risk
  • Higher potential for misuse
  • Examples: Adderall, Vyvanse, Dexedrine

Choosing Between Classes

Start with Methylphenidate if:

  • History of substance use
  • Concerns about side effects
  • Comorbid mood disorders
  • Need smoother effect

Start with Amphetamines if:

  • Previous good response
  • Need stronger symptom control
  • Methylphenidate insufficient
  • Severe ADHD symptoms

Key Formulation Factors

  1. Enantiomer Composition
    • Amphetamines: D-amphetamine vs L-amphetamine
    • Methylphenidate: Dexmethylphenidate vs Levomethylphenidate
    • Different ratios affect potency and side effects
  2. Route of Administration
    • Primarily pills for adults
    • Alternatives: ODT, chewables, liquids, patches
  3. Release Mechanism
    • Immediate Release (IR): 3–6 hours
    • Extended Release (ER): 8–12 hours
    • Most adults benefit from ER formulations

Prodrugs

Lisdexamphetamine (Vyvanse):

  • Inactive until metabolized
  • Lower abuse potential
  • Smoother action
  • Once-daily dosing

Serdexmethylphenidate (Azstarys):

  • Combines immediate and extended control
  • Gradual metabolism

Practical Guidelines

  1. Starting Treatment
    • Begin with long-acting formulation
    • Use symptom rating scales (ASRS)
    • 1–2 month initial trial
    • Aim for 50% symptom improvement
  2. Dosing
    • Start low, titrate slowly
    • Amphetamine: 5–10 mg daily
    • Methylphenidate: 10–20 mg daily
    • Adjust based on response
  3. When to Switch
    • Insufficient response
    • Significant side effects
    • ~30% who don't respond to one class will respond to the other

IR Stimulant Uses

  • Targeted symptom needs
  • Variable schedules
  • Side effect management
  • Reduced long-term exposure
  • Individual metabolism considerations

Adult ADHD: Comprehensive Diagnosis and Treatment — Audio Course

Full Audio Course & CME

Adult ADHD: Comprehensive Diagnosis and Treatment

Gregory Malzberg, MD  ·  2.25-Hour Course

In this audio course, Dr. Gregory Malzberg teaches the latest approaches to understanding, diagnosing, and managing ADHD in adult patients. This Continuing Education activity is designed for busy clinicians who want to learn while driving, walking, or multitasking. Whether refining your skills or building a foundation, this course is designed to provide practical, evidence-based strategies that you can apply in your practice.

Get the Course
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2782224449.jpg
    General Psychiatry

    Gender Affirming Care: Fall of the House of Hopkins

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.